Alnylam Pharmaceuticals (A1LN34.SA) Q1 2015 Earnings

12FebConfirmed
Q2 2014
Q3 2014
Q4 2014
Q1 2015
-1.66
-1.37
-1.08
-0.79

Details

Expected EPS
-1.6621184999999998
Actual EPS
-0.788802
Surprise EPS
0.87
Surprise Percent
+52.54%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -0.788802 per share for Q1 2015.

0 Comments

Share your thoughts